scispace - formally typeset
J

James M. Binley

Researcher at Aaron Diamond AIDS Research Center

Publications -  60
Citations -  9708

James M. Binley is an academic researcher from Aaron Diamond AIDS Research Center. The author has contributed to research in topics: Epitope & Antibody. The author has an hindex of 42, co-authored 59 publications receiving 9384 citations. Previous affiliations of James M. Binley include New York University & Torrey Pines Institute for Molecular Studies.

Papers
More filters
Journal ArticleDOI

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

TL;DR: CD4 binding, although not absolutely necessary for the gp120–CCR-5 interaction, greatly increases its efficiency, and interference with HIV-1 binding to one or both of its receptors (CD4 and CCR-5) may be an important mechanism of virus neutralization.
Journal ArticleDOI

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

TL;DR: Broadly neutralizing monoclonal antibodies are potentially important tools in human immunodeficiency virus type 1 (HIV-1) vaccine design and have implications for passive-immunization studies in countries where clade C viruses are common, given that only MAbs b12 and 4E10 were effective against viruses from this clade.
Journal ArticleDOI

A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

TL;DR: A disulfide bond is introduced between the C-terminal region of gp120 and the immunodominant segment of the gp41 ectodomain, producing a properly folded envelope glycoprotein complex which has antigenic properties which resemble those of the virion-associated complex.
Journal ArticleDOI

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

TL;DR: It is confirmed that HIV-1 and HCV are produced and cleared extremely rapidly, up to ten times higher than previous estimates, whereas HCV clearance is similar to previous estimates.